
About Vitl
Vitl is a Healthcare company based in London (United Kingdom) founded in 2015 by Oliver Bolton. Personalized nutritional supplements are provided based on biochemical tests. Vitl has raised $13.39 million across 6 funding rounds from investors including Cazoo, Nogra Pharma and Alex Chesterman. The company has 17 employees. Vitl was last valued at $6.99 million in December 2015. Its website vitl.com draws about 101 thousand monthly visits. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Personalized. Its legal entity is SEQUENCE NUTRITION LIMITED.
Company details
Vitl was founded in 2015 in London, United Kingdom, within the health and wellness sector. Personalized vitamins and nutritional supplements are offered through professional consultations and at-home DNA and vitamin blood tests. Operations focus on biochemical analysis to tailor recommendations for individual needs. Services are delivered primarily in the UK market, emphasizing evidence-based nutrition solutions.
- Total Equity Funding$13.39M (USD)
in 6 rounds
- Latest Funding Round$8.79M (USD), Series A
Feb 2022
- InvestorsCazoo
& 37 more
- Employee Count17
Funding Insights of Vitl
Vitl has successfully raised a total of $13.39M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $8.79 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.39M
- Total Rounds 6
- Last Round Series A β $8.79M
- First Round $237,400
(Jun 2015)
- Investors Count 38
All 6 funding rounds of Vitl with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2022 | $8.79M | Series A | β | Ornament | |
| Aug 2018 | $1.2M | Seed | β | β | β |
| Nov 2017 | $733,019 | Seed | β | ACF Investors | |
| Sep 2016 | $1.5M | Seed | β | Alex Chesterman, David de Rothschild | β |
| Dec 2015 | $929,800 | Angel Round | $6.99M | Till Bechtolsheimer | |
| Jun 2015 | $237,400 | Angel Round | $2.41M | Robert Cranborne |
| Date | Valuation | Stage |
|---|---|---|
| Dec 2015 | $6.99M | β’β’β’β’β’β’β’β’ |
| Jun 2015 | $2.41M | β’β’β’β’β’β’β’β’ |
Last known valuation $6.99M (Dec 2015). 38 investors in total: 6 institutional and 32 angel.
Investors in Vitl
Vitl has secured backing from 38 investors, including angel, institutional, and venture fund investors. Prominent investors backing the company include Cazoo, Nogra Pharma and Alex Chesterman.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed-stage tech-focused VC firm investing primarily in the UK | samos.vc | London, United Kingdom | ||
Venture capital fund focused on series A stage hardware, future work, commerce, and digital media companies | c4v.com | Paris, France | ||
Venture capital firm focused on angel investments | acfinvestors.com | Sheffield, United Kingdom | ||
Online dealer of second-hand cars | 2018 | cazoo.co.uk | London, United Kingdom | |
Delivers advanced mobile apps for efficient tracking of lab test results. | 2018 | ornament.health | Switzerland | |
Therapeutics for immune-mediated inflammatory diseases are developed. | 2005 | nographarma.com | Dublin, Ireland | |
AC Alex Chesterman | unknown_a895bd19f134426aa | |||
RP Richard Pennycook | unknown_23791b463eca4c408 | |||
AE Alexander Edward Chesterman | British entrepreneur, founder of Cazoo, active angel investor in tech startups | unknown_149ee0d22c7048328 | ||
SD Simon Duffy | Angel investor, co-founder of Bulldog Skincare, active in Indian startup ecosystem | unknown_d757a662fb9a427d8 |
Investor details for Vitl
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Vitl
8 people are tracked at Vitl (6 in leadership, 2 in team); the tracked headcount is 17.
| Name | Role | Group |
|---|---|---|
Oliver Bolton | Co-Founder | Leadership |
Makan Houston | Head of Tech | Leadership |
Jonathan Relph | CEO & Founder | Leadership |
Max Adorian | Head of Special Projects | Leadership |
Monal Wadhera | Medical Director | Leadership |
Joe Mangan | Head Of Operations | Leadership |
Garth Wood | Backend Team Lead | Team |
Aisling Cowell (McBride) | Performance Marketing Lead | Team |
Complete people profiles for Vitl
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Vitl
4 dated milestones of Vitl across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Vitl is founded.
- Funding First funding round of $237K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $8.8M.
Web traffic of Vitl
The website of Vitl (vitl.com) receives about 101.4K visits a month.
- Monthly visits101.4K
▲ 45.4% vs previous month
Websites whose visitors overlap most with Vitl. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| alyvewellness.com | 100% | 120.3K | #328,891 | View details | |
myvitamins.com | myvitamins.com | 84% | #189,581 | β | |
| skinkraft.com | 84% | 510.5K | #117,198 | View details | |
| vitaminbuddy.co.uk | 84% | 680.7K | #8,514,683 | View details | |
| happytuesdays.com | 77% | #872,137 | View details | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 15 similar websites and full traffic analytics for Vitl
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vitl
Complete news archive for Vitl
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vitl
Vitl was founded in 2015.
Vitl is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Vitl is a funded company, having raised a total of $13.39M across 6 funding rounds to date. The company's 1st funding round was a Angel Round of $237.4K, raised on Jun 2015.
Vitl has 17 employees.
Vitl was founded in 2015 in London, United Kingdom, within the health and wellness sector. Personalized vitamins and nutritional supplements are offered through professional consultations and at-home DNA and vitamin blood tests. Operations focus on biochemical analysis to tailor recommendations for individual needs. Services are delivered primarily in the UK market, emphasizing evidence-based nutrition solutions.
Vitl has 38 investors. Key investors include Cazoo, Nogra Pharma, Alex Chesterman, Richard Pennycook, and Ornament.
The valuation of Vitl is $6.99M as of Dec 2015.
Vitl operates through Sequence Nutrition Limited.
The website of Vitl receives about 101 thousand visits a month.
